Comorbid medical illness as a predisposing factor for the treatment-resistant depression. Part 2: Principles of rational use of antidepressants in general medical practice
Abstract
Given the differences in the pharmacological and clinical effects of antidepressants, criteria for their differential choice in the treatment of depression associated with comorbid medical illnesses are suggested. Based on these criteria and general rules of clinical pharmacology, principles of antidepressant treatment in patients with comorbid medical illnesses aimed to optimize the therapeutic process and to prevent treatment resistance are developed.
About the Authors
M. Yu. Popov
V.M. Bekhterev National medical research center of psychiatry and neurology
Russian Federation
Russian Federation
V. L. Kozlovskiy
V.M. Bekhterev National medical research center of psychiatry and neurology
Russian Federation
Russian Federation
References
1. Быков Ю.В., Беккер Р.А., Резников М.К. Депрессии и резистентность (практическое руководство). - М.: РИОР: ИНФРА-М. - 2013. - 374 с.
2. Выборных Д.Э., Кикта С.В. Лечение депрессий в гастроэнтерологической практике // Клинические перспективы гастроэнтерологии, гепатологии. - 2010. - № 6. - С. 21-28.
3. Мазо Г.Э., Незнанов Н.Г. Терапевтически резистентные депрессии. - СПб: ООО «Береста». - 2012. - 448 с.
4. Малин Д.И. Побочное действие психотропных средств. - М.: Вузовская книга. - 2000. - 207 с.
5. Образовательная программа по депрессивным расстройствам (редакция 2008 г.) / Под ред. B.Н. Краснова. - Т. 2: Депрессия и соматические заболевания. - М.: Московский НИИ психиатрии. - 2010. - 171 с.
6. Попов М.Ю. Современные антидепрессанты: клинические перспективы нейрохимической селективности // Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева. - 2004. - № 3. - С. 5-8.
7. Попов М.Ю. Коморбидная соматическая патология как предпосылка терапевтической резистентности при депрессии. Сообщение 1: Механизмы формирования резистентности // Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева. - 2016. - № 4. - C. 66-72.
8. Психические расстройства (диагностика и терапия в общемедицинской практике) / Под ред. Ю.А. Александровского. - М.: Гэотар-Медиа. - 2007. - 240 с.
9. Bauer M., Pfennig A., Severus E. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders // World J. Biol. Psychiatry. - 2013 -Vol.14(5). - P. 334-385.
10. Caraci F., Crupi R., Drago F., Spina E. Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract // Curr. Drug Me tab. - 2011. - Vol.12(6). - P. 570-577.
11. Iosifescu D.V. Treating depression in the medically ill // Psychiatr. Clin. North. Am. - 2007. - Vol. 30(1). - P. 77-90.
12. Linde K., Kriston L., Rücker G. et al. Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis // Ann. Fam. Med. - 2015. - Vol. 13 (1). - P. 69-79.
13. Manolopoulos V.G., Ragia G., Alevizopoulos G. Pharmacokinetic interactions of selective serotonin reuptake inhibitors with other commonly prescribed drugs in the era of pharmacogenomics // Drug Metabol. Drug Interact. - 2012. - Vol. 27(1). - P. 19-31.
14. Rayner L., Price A., Evans A. et al. Antidepressants for depression in physically ill people // Cochrane Database Syst. Rev. - 2010. - № 3. - CD007503.
15. Sager J.E., Lutz J.D., Foti R.S. et al. Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4 // Clin. Pharmacol. Ther. - 2014. - Vol. 95(6). - P. 653-662.
16. Sartorius N., Baghai T.C., Baldwin D.S. et al. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence // Int. J. Neuropsychopharmacol. - 2007. - Suppl. 1. - P. 1-207.
17. Stahl S.M. Stahl’s essential psychopharmacology: neuroscientific basis and practical application, 3rd ed. - Cambridge University Press. - 2008. - 1117p.
18. Taylor D., Sparshatt A., Varma S., Olofinjana O. Antidepressant efficacy of agomelatine: Meta-analysis of published and unpublished studies // B.M. J. - 2014. - Vol. 348. - G. 1888.
Review
For citations:
Popov M.Yu., Kozlovskiy V.L. Comorbid medical illness as a predisposing factor for the treatment-resistant depression. Part 2: Principles of rational use of antidepressants in general medical practice. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2017;(3):89-95. (In Russ.)
Views:
538
Email this article 